OLD Point Trust & Financial Services N A Trims Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

OLD Point Trust & Financial Services N A lowered its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 15.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 850 shares of the company’s stock after selling 150 shares during the quarter. OLD Point Trust & Financial Services N A’s holdings in Church & Dwight were worth $89,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CHD. Teacher Retirement System of Texas bought a new stake in Church & Dwight during the 4th quarter worth approximately $240,000. Royal London Asset Management Ltd. increased its stake in shares of Church & Dwight by 4.6% in the fourth quarter. Royal London Asset Management Ltd. now owns 466,144 shares of the company’s stock worth $48,810,000 after purchasing an additional 20,433 shares in the last quarter. VSM Wealth Advisory LLC purchased a new stake in shares of Church & Dwight in the fourth quarter worth $92,000. Generali Asset Management SPA SGR bought a new stake in shares of Church & Dwight during the 4th quarter valued at $4,664,000. Finally, Evoke Wealth LLC lifted its stake in shares of Church & Dwight by 0.9% during the 4th quarter. Evoke Wealth LLC now owns 13,119 shares of the company’s stock valued at $1,374,000 after buying an additional 119 shares in the last quarter. 86.60% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Church & Dwight

In other Church & Dwight news, EVP Rene Hemsey sold 11,060 shares of the stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total transaction of $1,216,378.80. Following the sale, the executive vice president now owns 6,437 shares of the company’s stock, valued at approximately $707,941.26. This trade represents a 63.21 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the business’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the completion of the transaction, the executive vice president now directly owns 10,497 shares of the company’s stock, valued at approximately $1,217,442.06. The trade was a 83.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 65,570 shares of company stock valued at $7,538,449 in the last ninety days. Corporate insiders own 2.00% of the company’s stock.

Church & Dwight Stock Performance

Shares of Church & Dwight stock opened at $108.11 on Thursday. The stock’s fifty day moving average is $107.19 and its two-hundred day moving average is $105.83. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $26.59 billion, a PE ratio of 45.62, a price-to-earnings-growth ratio of 3.32 and a beta of 0.57. Church & Dwight Co., Inc. has a 52 week low of $96.35 and a 52 week high of $116.46.

Church & Dwight (NYSE:CHD) last released its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the previous year, the business posted $0.65 earnings per share. As a group, analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Friday, February 14th were issued a dividend of $0.295 per share. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a yield of 1.09%. The ex-dividend date was Friday, February 14th. Church & Dwight’s dividend payout ratio (DPR) is presently 49.79%.

Wall Street Analyst Weigh In

CHD has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. decreased their price target on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a report on Friday, February 21st. Truist Financial lifted their target price on Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, February 3rd. Barclays upped their price target on Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research note on Tuesday, February 4th. Stifel Nicolaus lifted their price objective on shares of Church & Dwight from $103.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 3rd. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $105.00 target price on shares of Church & Dwight in a research report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $111.56.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.